Related references
Note: Only part of the references are listed.Conventional MRI features of adult diffuse glioma molecular subtypes: a systematic review
Arian Lasocki et al.
NEURORADIOLOGY (2021)
Characteristics of IDH-mutant gliomas with non-canonical IDH mutation
L. Poetsch et al.
JOURNAL OF NEURO-ONCOLOGY (2021)
The 2021 WHO Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
NEURO-ONCOLOGY (2021)
Advanced imaging parameters improve the prediction of diffuse lower-grade gliomas subtype, IDH mutant with no 1p19q codeletion: added value to the T2/FLAIR mismatch sign
Min Kyoung Lee et al.
EUROPEAN RADIOLOGY (2020)
World Health Organization Grade II/III Glioma Molecular Status: Prediction by MRI Morphologic Features and Apparent Diffusion Coefficient
John Maynard et al.
RADIOLOGY (2020)
Diffusion-and Perfusion-Weighted Magnetic Resonance Imaging Methods in Nonenhancing Gliomas
Hatham Alkanhal et al.
WORLD NEUROSURGERY (2020)
Deep learning can see the unseeable: predicting molecular markers from MRI of brain gliomas
P. Korfiatis et al.
CLINICAL RADIOLOGY (2019)
Multi-parametric MR Imaging Biomarkers Associated to Clinical Outcomes in Gliomas: A Systematic Review
Miquel Oltra-Sastre et al.
CURRENT MEDICAL IMAGING (2019)
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groups
Tareq A. Juratli et al.
JOURNAL OF NEURO-ONCOLOGY (2019)
Low-Grade Glioma Radiotherapy Treatment and Trials
Tony J. C. Wang et al.
NEUROSURGERY CLINICS OF NORTH AMERICA (2019)
Glioma epigenetics: From subclassification to novel treatment options
Olga Gusyatiner et al.
SEMINARS IN CANCER BIOLOGY (2018)
Diffusion-Weighted Imaging and Diffusion Tensor Imaging for Differentiating High-Grade Glioma from Solitary Brain Metastasis: A Systematic Review and Meta-Analysis
C. H. Suh et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2018)
The T2-FLAIR mismatch sign as an imaging marker for non-enhancing IDH-mutant, 1p/19q-intact lower-grade glioma: a validation study
Martinus P. G. Broen et al.
NEURO-ONCOLOGY (2018)
Application of a Simplified Method for Estimating Perfusion Derived from Diffusion-Weighted MR Imaging in Glioma Grading
Mengqiu Cao et al.
FRONTIERS IN AGING NEUROSCIENCE (2018)
Distribution of EGFR amplification, combined chromosome 7 gain and chromosome 10 loss, and TERT promoter mutation in brain tumors and their potential for the reclassification of IDHwt astrocytoma to glioblastoma
Damian Stichel et al.
ACTA NEUROPATHOLOGICA (2018)
Prediction of genetic subgroups in adult supra tentorial gliomas by pre- and intraoperative parameters
Shunsuke Nakae et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
Histogram analysis of diffusion kurtosis imaging estimates for in vivo assessment of 2016 WHO glioma grades: A cross-sectional observational study
Johann-Martin Hempel et al.
EUROPEAN JOURNAL OF RADIOLOGY (2017)
Reliability of noncontrast-enhancing tumor as a biomarker of IDH1 mutation status in glioblastoma
Arian Lasocki et al.
JOURNAL OF CLINICAL NEUROSCIENCE (2017)
Perfusion and diffusion MRI signatures in histologic and genetic subtypes of WHO grade II-III diffuse gliomas
Kevin Leu et al.
JOURNAL OF NEURO-ONCOLOGY (2017)
The utility of diffusion MRI with quantitative ADC measurements for differentiating high-grade from low-grade cerebral gliomas: Evidence from a meta-analysis
Li Zhang et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2017)
MRI features predict survival and molecular markers in diffuse lower-grade gliomas
Hao Zhou et al.
NEURO-ONCOLOGY (2017)
Biopsy versus resection for the management of low-grade gliomas
Bowen Jiang et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2017)
Diffuse low-grade glioma: a review on the new molecular classification, natural history and current management strategies
P. D. Delgado-Lopez et al.
CLINICAL & TRANSLATIONAL ONCOLOGY (2017)
Noninvasive Assessment of IDH Mutational Status in World Health Organization Grade II and III Astrocytomas Using DWI and DSC-PWI Combined with Conventional MR Imaging
Z. Xing et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2017)
The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary
David N. Louis et al.
ACTA NEUROPATHOLOGICA (2016)
The role of neuropathology in the management of patients with diffuse low grade glioma A systematic review and evidence-based clinical practice guideline
Daniel P. Cahill et al.
JOURNAL OF NEURO-ONCOLOGY (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
PCR-Based Simple Subgrouping Is Validated for Classification of Gliomas and Defines Negative Prognostic Copy Number Aberrations in IDH Mutant Gliomas
Shunsuke Nakae et al.
PLOS ONE (2015)
International Society of Neuropathology-Haarlem Consensus Guidelines for Nervous System Tumor Classification and Grading
David N. Louis et al.
BRAIN PATHOLOGY (2014)
Diffusion-Weighted Imaging in Cancer: Physical Foundations and Applications of Restriction Spectrum Imaging (vol 74, pg 4638, 2014)
Nathan S. White et al.
CANCER RESEARCH (2014)
Comparative study of IDH1 mutations in gliomas by immunohistochemistry and DNA sequencing
Shipra Agarwal et al.
NEURO-ONCOLOGY (2013)
The Correlation between Apparent Diffusion Coefficient and Tumor Cellularity in Patients: A Meta-Analysis
Lihua Chen et al.
PLOS ONE (2013)
Interobserver variation of the histopathological diagnosis in clinical trials on glioma: a clinician's perspective
Martin J. van den Bent
ACTA NEUROPATHOLOGICA (2010)
Technology Insight: water diffusion MRI - a potential new biomarker of response to cancer therapy
Daniel M. Patterson et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2008)
Share Paper
